Frehemgo Denecimig EU Approval: Novo’s Monthly Haemophilia A Shot Takes On Hemlibra
The EU has approved Novo Nordisk Frehemgo (denecimig), a monthly, fortnightly or weekly pen for haemophilia A with or without inhibitors.
The EU has approved Novo Nordisk Frehemgo (denecimig), a monthly, fortnightly or weekly pen for haemophilia A with or without inhibitors.